Genmab reported DKK7.89B in Cash and Equivalent for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 1888.02M 1760.59M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Amarin AMRN:US $ 290.99M 104.03M
Amgen AMGN:US $ 6112M 154M
AstraZeneca AZN:LN 7636M 196M
Bayer BAYN:GR € 5550M 1359M
Biomarin Pharmaceutical BMRN:US $ 667.31M 18.16M
Bluebird Bio BLUE:US $ 439.71M 122.01M
Fresenius Medical Care FME:GR € 1073M 8.54M
Genmab GEN:DC DK 7892M 632M
GlaxoSmithKline GSK:LN 4757M 1535M
GN Store Nord GN:DC DK 1898M 241M
GRIFOLS GRF:SM € 380.98M 198.67M
Hikma Pharmaceutical HIK:LN 323M 90M
Immunogen IMGN:US $ 283.12M 10.74M
Insmed INSM:US $ 409.75M 123M
Lonza Group LONN:SW 501M 6M
Novartis NOVN:VX SF 3801M 5857M
Regeneron Pharmaceuticals REGN:US $ 1437.9M 755.8M
Seattle Genetics SGEN:US $ 373.71M 184.71M